nejm semaglutide cardiovascular New in the May 29, 2025, issue of NEJM: Sotatercept in Pulmonary Arterial Hypertension (ZENITH phase 3 trial) https://nej.md/4iYkLbj Oral and Outcomes (SOUL trial) https://nej.md/4hHII5M Upadacitinib for Giant-Cell Arteritis FLOWing with the SemagluTIDE —

Marcelin, G

Although we adjusted for age in our ANCOVA analysis, we were interested in observing the effect of total GSH levels upon age

The current study investigated the effects of well-characterized butyrate-producing bacteria Clostridium butyricum CGMCC0313.1 (CB0313.1) on hyperglycemia and associated metabolic dysfunction in two diabetic mouse models

Those with evidence of central obesity and elevated waist circumference may particularly benefit given the metabolic risks associated with visceral fat accumulation, though this is not an FDA-labeled selection criterion

Comprehensive Approach: The dual action of Tirzepatide addresses both blood sugar regulation and weight management, offering a holistic approach to improving health outcomes for our patients